Free Trial

Aspire Biopharma (ASBP) SEC Filings & 10K Form

Aspire Biopharma logo
$0.35 +0.03 (+10.10%)
As of 07/16/2025 04:00 PM Eastern

Recent Aspire Biopharma SEC Filings

DateFilerForm TypeView
06/18/2025
4:29 PM
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
4:25 PM
Aspire Biopharma Holdings, Inc. (Issuer)
Aspire Biopharma Holdings, Inc. (Issuer)
Aspire Biopharma Holdings, Inc. (Issuer)
Aspire Biopharma (Issuer)
Fell Donald G. (Reporting)
Form 4/A
06/10/2025
7:30 AM
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2025
11:15 PM
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma (Filer)
Form EFFECT
05/19/2025
7:30 PM
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma (Subject)
Friedman Lance (Filed by)
Form SCHEDULE 13G/A
05/14/2025
3:45 PM
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2025
4:15 PM
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma (Subject)
Friedman Lance (Filed by)
Form SCHEDULE 13G/A
04/30/2025
3:57 PM
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
6:48 PM
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma (Subject)
Friedman Lance (Filed by)
Form SCHEDULE 13G/A
04/21/2025
11:15 PM
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma (Filer)
Form EFFECT
04/17/2025
3:22 PM
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma (Subject)
Friedman Lance (Filed by)
Form SCHEDULE 13G/A
04/09/2025
5:21 AM
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/07/2025
6:30 AM
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/04/2025
4:28 PM
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma (Subject)
Friedman Lance (Filed by)
Form SCHEDULE 13G/A
03/31/2025
4:28 PM
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma (Filer)
Form NT 10-K
03/28/2025
4:29 PM
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma (Subject)
Friedman Lance (Filed by)
Form SCHEDULE 13G/A
03/20/2025
8:58 PM
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma (Subject)
Friedman Lance (Filed by)
Form SCHEDULE 13G/A
02/26/2025
8:20 PM
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma Holdings, Inc. (Subject)
Aspire Biopharma (Subject)
Friedman Lance (Filed by)
Form SCHEDULE 13G
02/21/2025
3:59 PM
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
3:45 PM
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma Holdings, Inc. (Filer)
Aspire Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
2:58 PM
Nasdaq Stock Market LLC (Filed by)
PowerUp Acquisition Corp. (Subject)
PowerUp Acquisition Corp. (Subject)
PowerUp Acquisition Corp. (Subject)
Aspire Biopharma (Subject)
Form 25-NSE
02/10/2025
3:20 PM
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
11:15 PM
Aspire BioPharma Inc. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form EFFECT
01/14/2025
3:35 PM
Aspire BioPharma Inc. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form 424B3
01/08/2025
4:13 PM
Aspire BioPharma Inc. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form S-4/A
12/26/2024
3:05 PM
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
3:06 PM
PowerUp Acquisition Corp. (Subject)
PowerUp Acquisition Corp. (Subject)
PowerUp Acquisition Corp. (Subject)
Aspire Biopharma (Subject)
Form 425
12/23/2024
4:30 PM
Aspire BioPharma Inc. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form S-4/A
12/10/2024
4:22 PM
Aspire BioPharma Inc. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form S-4/A
10/24/2024
4:18 PM
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form 10-Q/A
10/24/2024
4:20 PM
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form 10-Q/A
10/24/2024
5:07 AM
Aspire BioPharma Inc. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form S-4/A
10/04/2024
4:25 PM
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:27 PM
PowerUp Acquisition Corp. (Subject)
PowerUp Acquisition Corp. (Subject)
PowerUp Acquisition Corp. (Subject)
Aspire Biopharma (Subject)
Form 425
09/06/2024
4:10 PM
Aspire BioPharma Inc. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form S-4
Registration statement under Securities Act of 1933  
09/03/2024
7:01 AM
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
4:25 PM
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
4:26 PM
PowerUp Acquisition Corp. (Subject)
PowerUp Acquisition Corp. (Subject)
PowerUp Acquisition Corp. (Subject)
Aspire Biopharma (Subject)
Form 425
08/14/2024
8:35 PM
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form NT 10-Q
07/30/2024
9:56 AM
BANK OF NOVA SCOTIA (Filed by)
PowerUp Acquisition Corp. (Subject)
PowerUp Acquisition Corp. (Subject)
PowerUp Acquisition Corp. (Subject)
Aspire Biopharma (Subject)
Form SC 13G/A
07/23/2024
6:00 AM
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
PowerUp Acquisition Corp. (Filer)
Aspire Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Elon’s BIGGEST warning yet? (Ad)

Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.

Click here to see why Tesla's about to prove everyone wrong... again.
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ASBP) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners